Black Men and Prostate Cancer: RCCA Oncologists Discuss 5 Facts to Know and 1 Step to Take
While prostate cancer can affect men of any racial or ethnic background, it poses a particular threat to Black men.
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Regional Cancer Care Associates, LLC, or RCCA, is recognized nationally as a leader in providing evidence-driven, value-based oncology services. From helping to pioneer the Centers for Medicare and Medicaid Services’ (CMS) Oncology Care Model (OCM) to employing sophisticated analytics to ensure that the right patient receives the right treatment at the right time, RCCA has played a central role in the movement to provide clinically effective, cost-efficient care.
To better understand the RCCA experience and the lessons it offers other cancer care organizations, the editors of the Journal of Clinical Pathways recently asked RCCA President and Chief Executive Officer Terrill Jordan to share his insights and expertise. The interview can be read here.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
While prostate cancer can affect men of any racial or ethnic background, it poses a particular threat to Black men.
This passion and dedication was once again recognized when 16 doctors from RCCA were named 2023 Top Cancer Doctors as selected by health care research and information company Castle Connolly.
Regional Cancer Care Associates’ expert oncologists and hematologists bring the latest cancer therapies, treatment strategies and clinical trials to convenience, community-based care centers near your home.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.